Literature DB >> 27986810

Genetic Variations in the Human G Protein-coupled Receptor Class C, Group 6, Member A (GPRC6A) Control Cell Surface Expression and Function.

Stine Jørgensen1, Christian Theil Have2, Christina Rye Underwood1, Lars Dan Johansen1, Petrine Wellendorph1, Anette Prior Gjesing2, Christinna V Jørgensen1, Shi Quan3, Gao Rui3, Asuka Inoue4,5, Allan Linneberg6,7,8, Niels Grarup2, Wang Jun3, Oluf Pedersen2, Torben Hansen2, Hans Bräuner-Osborne9.   

Abstract

GPRC6A is a G protein-coupled receptor activated by l-amino acids, which, based on analyses of knock-out mice, has been suggested to have physiological functions in metabolism and testicular function. The human ortholog is, however, mostly retained intracellularly in contrast to the cell surface-expressed murine and goldfish orthologs. The latter orthologs are Gq-coupled and lead to intracellular accumulation of inositol phosphates and calcium release. In the present study we cloned the bonobo chimpanzee GPRC6A receptor, which is 99% identical to the human receptor, and show that it is cell surface-expressed and functional. By analyses of chimeric human/mouse and human/bonobo receptors, bonobo receptor mutants, and the single nucleotide polymorphism database at NCBI, we identify an insertion/deletion variation in the third intracellular loop responsible for the intracellular retention and lack of function of the human ortholog. Genetic analyses of the 1000 genome database and the Inter99 cohort of 6,000 Danes establish the distribution of genotypes among ethnic groups, showing that the cell surface-expressed and functional variant is much more prevalent in the African population than in European and Asian populations and that this variant is partly linked with a stop codon early in the receptor sequence (rs6907580, amino acid position 57). In conclusion, our data solve a more than decade-old question of why the cloned human GPRC6A receptor is not cell surface-expressed and functional and provide a genetic framework to study human phenotypic traits in large genome sequencing projects linked with physiological measurement and biomarkers.
© 2017 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  7-helix receptor; G protein-coupled receptor (GPCR); GPRC6A receptor; cell surface receptor; human genetics; molecular pharmacology; third intracellular loop

Mesh:

Substances:

Year:  2016        PMID: 27986810      PMCID: PMC5270492          DOI: 10.1074/jbc.M116.756577

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  40 in total

1.  Enhanced voluntary wheel running in GPRC6A receptor knockout mice.

Authors:  Christoffer Clemmensen; Christian Pehmøller; Anders B Klein; Cecilia Ratner; Jørgen F P Wojtaszewski; Hans Bräuner-Osborne
Journal:  Physiol Behav       Date:  2013-05-14

2.  GPRC6A mediates the effects of L-arginine on insulin secretion in mouse pancreatic islets.

Authors:  Min Pi; Yunpeng Wu; Nataliya I Lenchik; Ivan Gerling; L Darryl Quarles
Journal:  Endocrinology       Date:  2012-08-07       Impact factor: 4.736

3.  Deorphanization of GPRC6A: a promiscuous L-alpha-amino acid receptor with preference for basic amino acids.

Authors:  Petrine Wellendorph; Kasper B Hansen; Anders Balsgaard; Jeremy R Greenwood; Jan Egebjerg; Hans Bräuner-Osborne
Journal:  Mol Pharmacol       Date:  2004-12-02       Impact factor: 4.436

4.  Robust GLP-1 secretion by basic L-amino acids does not require the GPRC6A receptor.

Authors:  Christoffer Clemmensen; Christinna V Jørgensen; Sanela Smajilovic; Hans Bräuner-Osborne
Journal:  Diabetes Obes Metab       Date:  2017-01-19       Impact factor: 6.577

5.  No evidence for a bone phenotype in GPRC6A knockout mice under normal physiological conditions.

Authors:  Petrine Wellendorph; Lars Dan Johansen; Anders A Jensen; Emilio Casanova; Martin Gassmann; Pierre Deprez; Philippe Clément-Lacroix; Bernhard Bettler; Hans Bräuner-Osborne
Journal:  J Mol Endocrinol       Date:  2008-12-22       Impact factor: 5.098

Review 6.  The GPCR, class C, group 6, subtype A (GPRC6A) receptor: from cloning to physiological function.

Authors:  C Clemmensen; S Smajilovic; P Wellendorph; H Bräuner-Osborne
Journal:  Br J Pharmacol       Date:  2014-03       Impact factor: 8.739

7.  Extracellular Ca2+ is a danger signal activating the NLRP3 inflammasome through G protein-coupled calcium sensing receptors.

Authors:  Manuela Rossol; Matthias Pierer; Nora Raulien; Dagmar Quandt; Undine Meusch; Kathrin Rothe; Kristin Schubert; Torsten Schöneberg; Michael Schaefer; Ute Krügel; Sanela Smajilovic; Hans Bräuner-Osborne; Christoph Baerwald; Ulf Wagner
Journal:  Nat Commun       Date:  2012       Impact factor: 14.919

8.  GPRC6a is not required for the effects of a high-protein diet on body weight in mice.

Authors:  James S Kinsey-Jones; Amin Alamshah; Anne K McGavigan; Eleanor Spreckley; Katherine Banks; Nicholas Cereceda Monteoliva; Mariana Norton; Gavin A Bewick; Kevin G Murphy
Journal:  Obesity (Silver Spring)       Date:  2015-05-09       Impact factor: 5.002

9.  L-arginine promotes gut hormone release and reduces food intake in rodents.

Authors:  A Alamshah; A K McGavigan; E Spreckley; J S Kinsey-Jones; A Amin; I R Tough; H C O'Hara; A Moolla; K Banks; R France; G Hyberg; M Norton; W Cheong; A Lehmann; S R Bloom; H M Cox; K G Murphy
Journal:  Diabetes Obes Metab       Date:  2016-04-01       Impact factor: 6.577

10.  An integrated map of genetic variation from 1,092 human genomes.

Authors:  Goncalo R Abecasis; Adam Auton; Lisa D Brooks; Mark A DePristo; Richard M Durbin; Robert E Handsaker; Hyun Min Kang; Gabor T Marth; Gil A McVean
Journal:  Nature       Date:  2012-11-01       Impact factor: 49.962

View more
  10 in total

1.  The GPRC6A receptor displays constitutive internalization and sorting to the slow recycling pathway.

Authors:  Stine Engesgaard Jacobsen; Ina Ammendrup-Johnsen; Anna Mai Jansen; Ulrik Gether; Kenneth Lindegaard Madsen; Hans Bräuner-Osborne
Journal:  J Biol Chem       Date:  2017-03-09       Impact factor: 5.157

2.  Human GPRC6A Mediates Testosterone-Induced Mitogen-Activated Protein Kinases and mTORC1 Signaling in Prostate Cancer Cells.

Authors:  Ruisong Ye; Min Pi; Mohammed M Nooh; Suleiman W Bahout; L Darryl Quarles
Journal:  Mol Pharmacol       Date:  2019-03-20       Impact factor: 4.436

Review 3.  Skeletal endocrinology: where evolutionary advantage meets disease.

Authors:  Nikolai Jaschke; Wolfgang Sipos; Lorenz C Hofbauer; Tilman D Rachner; Martina Rauner
Journal:  Bone Res       Date:  2021-05-28       Impact factor: 13.567

4.  CRISPR/Cas9 targeting of GPRC6A suppresses prostate cancer tumorigenesis in a human xenograft model.

Authors:  Ruisong Ye; Min Pi; John V Cox; Satoru K Nishimoto; L Darryl Quarles
Journal:  J Exp Clin Cancer Res       Date:  2017-06-28

5.  Humanized GPRC6AKGKY is a gain-of-function polymorphism in mice.

Authors:  Min Pi; Fuyi Xu; Ruisong Ye; Satoru K Nishimoto; Robert A Kesterson; Robert W Williams; Lu Lu; L Darryl Quarles
Journal:  Sci Rep       Date:  2020-07-07       Impact factor: 4.379

Review 6.  Osteocalcin‑GPRC6A: An update of its clinical and biological multi‑organic interactions (Review).

Authors:  Martha Cristina Diaz-Franco; Raul Franco-Diaz de Leon; Jose Rafael Villafan-Bernal
Journal:  Mol Med Rep       Date:  2018-11-05       Impact factor: 2.952

7.  Metabolic and skeletal homeostasis are maintained in full locus GPRC6A knockout mice.

Authors:  Christinna V Jørgensen; Sylvia J Gasparini; Jinwen Tu; Hong Zhou; Markus J Seibel; Hans Bräuner-Osborne
Journal:  Sci Rep       Date:  2019-04-12       Impact factor: 4.379

8.  Role of GPRC6A in Regulating Hepatic Energy Metabolism in Mice.

Authors:  Min Pi; Fuyi Xu; Ruisong Ye; Satoru K Nishimoto; Robert W Williams; Lu Lu; L Darryl Quarles
Journal:  Sci Rep       Date:  2020-04-29       Impact factor: 4.379

Review 9.  Advanced Therapeutic Options for Treatment of Metastatic Castration Resistant Prostatic Adenocarcinoma.

Authors:  Faiza Naseer; Tahir Ahmad; Kousain Kousar; Sadia Anjum
Journal:  Front Pharmacol       Date:  2021-11-10       Impact factor: 5.810

Review 10.  Explaining Divergent Observations Regarding Osteocalcin/GPRC6A Endocrine Signaling.

Authors:  Min Pi; Satoru Kenneth Nishimoto; L Darryl Quarles
Journal:  Endocrinology       Date:  2021-04-01       Impact factor: 4.736

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.